Change search
ReferencesLink to record
Permanent link

Direct link
SLC10A4 Is a Vesicular Amine-Associated Transporter Modulating Dopamine Homeostasis
Show others and affiliations
2015 (English)In: Biological Psychiatry, ISSN 0006-3223, E-ISSN 1873-2402, Vol. 77, no 6, 526-536 p.Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: The neuromodulatory transmitters, biogenic amines, have profound effects on multiple neurons and are essential for normal behavior and mental health. Here we report that the orphan transporter SLC10A4, which in the brain is exclusively expressed in presynaptic vesicles of monoaminergic and cholinergic neurons, has a regulatory role in dopamine homeostasis. METHODS: We used a combination of molecular and behavioral analyses, pharmacology, and in vivo amperometry to assess the role of SLC10A4 in dopamine- regulated behaviors. RESULTS: We show that SLC10A4 is localized on the same synaptic vesicles as either vesicular acetylcholine transporter or vesicular monoamine transporter 2. We did not find evidence for direct transport of dopamine by SLC10A4; however, synaptic vesicle preparations lacking SLC10A4 showed decreased dopamine vesicular uptake efficiency. Furthermore, we observed an increased acidification in synaptic vesicles isolated from mice over-expressing SLC10A4. Loss of SLC10A4 in mice resulted in reduced striatal serotonin, noradrenaline, and dopamine concentrations and a significantly higher dopamine turnover ratio. Absence of SLC10A4 led to slower dopamine clearance rates in vivo, which resulted in accumulation of extracellular dopamine. Finally, whereas SLC10A4 null mutant mice were slightly hypoactive, they displayed hypersensitivity to administration of amphetamine and tranylcypromine. CONCLUSIONS: Our results demonstrate that SLC10A4 is a vesicular monoaminergic and cholinergic associated transporter that is important for dopamine homeostasis and neuromodulation in vivo. The discovery of SLC10A4 and its role in dopaminergic signaling reveals a novel mechanism for neuromodulation and represents an unexplored target for the treatment of neurological and mental disorders.

Place, publisher, year, edition, pages
2015. Vol. 77, no 6, 526-536 p.
Keyword [en]
Acetylcholine, Amphetamine, Central nervous system, Cocaine, Noradrenaline, Serotonin, Synaptic transmission, Transmitter
National Category
Neurosciences Neurology
URN: urn:nbn:se:kth:diva-161944DOI: 10.1016/j.biopsych.2014.07.017ISI: 000349776000006PubMedID: 25176177ScopusID: 2-s2.0-84922930996OAI: diva2:801075
Swedish Research Council, 20114747, 2010-4394, 2007-3630/4479/5742EU, FP7, Seventh Framework Programme, 201 837

QC 20150408

Available from: 2015-04-08 Created: 2015-03-20 Last updated: 2015-04-08Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Rönnlund, Daniel
By organisation
Experimental Biomolecular Physics
In the same journal
Biological Psychiatry

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 50 hits
ReferencesLink to record
Permanent link

Direct link